Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEAMERICAN:CRFNYSEARCA:DIGNYSE:EATTSE:FGXNYSE:PMC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRFCornerstone Total Return Fund$7.41+0.7%$7.21$6.05▼$8.56$762.71M1.15677,360 shs427,866 shsDIGProShares Ultra Energy$47.40+0.2%$43.16$31.07▼$50.26$130.35M2.6878,186 shs39,622 shsEATBrinker International$47.61-0.8%$47.02$28.23▼$51.72$2.11B2.461.29 million shs772,594 shsFGXFaircourt Gold IncomeC$2.60C$2.32▼C$3.58C$7.21MN/A5,795 shs2,500 shsPMCPharmerica$0.00$22.00▼$29.50N/AN/A283,015 shsN/A20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRFCornerstone Total Return Fund0.00%-6.12%-1.64%+1.26%-2.57%DIGProShares Ultra Energy+1.20%+3.34%+7.55%+36.12%+17.60%EATBrinker International+3.94%+6.10%+4.25%+22.68%+22.11%FGXFaircourt Gold Income0.00%0.00%0.00%0.00%0.00%PMCPharmerica0.00%0.00%0.00%0.00%0.00%The #1 Biotech Stock to Have on Your Radar in 2024… (Ad)Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now!MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRFCornerstone Total Return FundN/AN/AN/AN/AN/AN/AN/AN/ADIGProShares Ultra EnergyN/AN/AN/AN/AN/AN/AN/AN/AEATBrinker International3.8602 of 5 stars2.13.00.01.82.50.83.8FGXFaircourt Gold IncomeN/AN/AN/AN/AN/AN/AN/AN/APMCPharmericaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRFCornerstone Total Return FundN/AN/AN/AN/ADIGProShares Ultra Energy0.00N/A$52.059.81% UpsideEATBrinker International2.18Hold$44.19-7.19% DownsideFGXFaircourt Gold IncomeN/AN/AN/AN/APMCPharmericaN/AN/AN/AN/ACurrent Analyst RatingsLatest PMC, CRF, EAT, FGX, and DIG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2024EATBrinker InternationalUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$46.00 ➝ $50.004/18/2024EATBrinker InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$48.00 ➝ $50.004/16/2024EATBrinker InternationalJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$47.00 ➝ $48.004/12/2024EATBrinker InternationalMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$36.00 ➝ $39.004/11/2024EATBrinker InternationalStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$50.00 ➝ $55.003/19/2024EATBrinker InternationalJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$44.00 ➝ $48.002/1/2024EATBrinker InternationalRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$43.00 ➝ $46.002/1/2024EATBrinker InternationalBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$52.00 ➝ $55.002/1/2024EATBrinker InternationalRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetStrong-Buy ➝ Strong-Buy$45.00 ➝ $50.00(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRFCornerstone Total Return FundN/AN/AN/AN/AN/AN/ADIGProShares Ultra EnergyN/AN/AN/AN/AN/AN/AEATBrinker International$4.13B0.51$6.83 per share6.97($3.24) per share-14.69FGXFaircourt Gold IncomeC$1.67M0.00N/A0.63C$3.59 per share0.00PMCPharmericaN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRFCornerstone Total Return FundN/AN/A0.00∞N/AN/AN/AN/AN/ADIGProShares Ultra EnergyN/AN/A0.00∞N/AN/AN/AN/AN/AEATBrinker International$102.60M$3.4113.9611.530.753.63%-113.41%7.07%4/30/2024 (Confirmed)FGXFaircourt Gold IncomeN/AC$0.2112.56N/AN/AN/AN/AN/AN/APMCPharmericaN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest PMC, CRF, EAT, FGX, and DIG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2024N/AEATBrinker International$1.15N/A-$1.15N/AN/AN/A 1/31/2024Q2 2024EATBrinker International$0.94$0.99+$0.05$1.04$1.08 billion$1.07 billionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRFCornerstone Total Return Fund$1.3518.22%-13.24%N/AN/ADIGProShares Ultra Energy$0.571.20%N/AN/AN/AEATBrinker InternationalN/AN/AN/AN/AN/AFGXFaircourt Gold IncomeC$0.29N/AN/A139.13%N/APMCPharmericaN/AN/AN/AN/AN/ALatest PMC, CRF, EAT, FGX, and DIG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/15/2024CRFCornerstone Total Return Fundmonthly$0.103717.5%6/14/20246/14/20246/28/20242/14/2024CRFCornerstone Total Return Fundmonthly$0.103717.5%6/14/20246/14/20246/28/20242/12/2024CRFCornerstone Total Return Fundmonthly$0.103717.3%5/14/20245/15/20245/31/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRFCornerstone Total Return FundN/AN/AN/ADIGProShares Ultra EnergyN/AN/AN/AEATBrinker InternationalN/A0.360.30FGXFaircourt Gold Income11.867.887.88PMCPharmericaN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRFCornerstone Total Return Fund10.41%DIGProShares Ultra EnergyN/AEATBrinker InternationalN/AFGXFaircourt Gold IncomeN/APMCPharmerica89.97%Insider OwnershipCompanyInsider OwnershipCRFCornerstone Total Return Fund14.50%DIGProShares Ultra EnergyN/AEATBrinker International1.50%FGXFaircourt Gold IncomeN/APMCPharmerica5.04%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCRFCornerstone Total Return FundN/A102.93 million88.01 millionNot OptionableDIGProShares Ultra EnergyN/A2.75 millionN/ANot OptionableEATBrinker International64,32344.23 million43.56 millionOptionableFGXFaircourt Gold IncomeN/A2.77 millionN/ANot OptionablePMCPharmericaN/AN/AN/ANot OptionablePMC, CRF, EAT, FGX, and DIG HeadlinesSourceHeadlineMedicine shortage hits TB elimination programme in Punemsn.com - March 30 at 4:53 PMFrom next month, PMC hospitals, maternity homes to get generic medicine storesmsn.com - November 22 at 6:36 AMDavenport Extreme Pools & Spas owner and spouse charged with fraud, theftbizjournals.com - October 6 at 6:03 PMPMC Prodigy 1 reviewwhathifi.com - September 14 at 10:50 PMPharmerica Stock Falls On Unusually High Volume (PMC)thestreet.com - May 25 at 8:22 AMTop Stories: Patient information exposed in PharMerica breachhealthcarefinancenews.com - May 24 at 8:39 PMPharMerica Notifies 5.8M Individuals of Healthcare Data Breachhealthitsecurity.com - May 19 at 12:25 PMActivities of Daily Living for Seniorshealth.usnews.com - April 20 at 2:20 AMWe can howl about staffing challenges, or start fixing themmcknights.com - April 18 at 12:13 AMPAC Profile: Pharmerica Corpopensecrets.org - April 18 at 12:13 AMGolden Livingforbes.com - February 24 at 12:56 AMGas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028marketwatch.com - January 17 at 9:51 AMKentucky orthopedic practice to relocatebeckersspine.com - December 27 at 2:02 PMGas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028marketwatch.com - November 10 at 9:28 PM9 Medford Residents To Participate In 2022 Pan-Mass Challengemsn.com - July 15 at 3:50 PMZero tolerance policy on irregularities in medical education system: PMCapp.com.pk - June 25 at 1:10 PMPMC among nation’s top-performing hospitals for treatment of heart attack patientsnews-expressky.com - May 25 at 7:28 PMCVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7Bthestreet.com - January 21 at 8:53 PMView | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiouslymsn.com - December 8 at 1:05 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesCharles Schwab Fortifies its Uptrend on EPS Beat April 23, 2024 10:15 AMView Charles Schwab Fortifies its Uptrend on EPS Beat Viking Therapeutics Surges Sentiment for Triple Threat GLP-1PillApril 3, 2024 6:20 AMView Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill5 Cheap Dividend Stocks: Which to Buy NowApril 1, 2024 9:55 AMView 5 Cheap Dividend Stocks: Which to Buy NowGE Aerospace is Ready for Liftoff After Strong EarningsApril 24, 2024 9:07 AMView GE Aerospace is Ready for Liftoff After Strong EarningsPVH Stock Gets 25% Discount: Is Now the Time to Buy?April 2, 2024 11:25 AMView PVH Stock Gets 25% Discount: Is Now the Time to Buy?All Headlines Company DescriptionsCornerstone Total Return FundNYSEAMERICAN:CRFCornerstone Total Return Fund, Inc. is a closed-ended equity mutual fund launched and managed by Cornerstone Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value and growth stocks of companies across all market capitalizations. The fund also invests through other closed-end investment companies and ETFs. It benchmarks the performance of its portfolio against the S&P 500 Index. Cornerstone Total Return Fund, Inc. was formed on March 16, 1973 and is domiciled in the United States.ProShares Ultra EnergyNYSEARCA:DIGProShares Ultra Oil & Gas (the fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Oil & Gas Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.Brinker InternationalNYSE:EATBrinker International, Inc., together with its subsidiaries, engages in the ownership, development, operation, and franchising of casual dining restaurants in the United States and internationally. It operates and franchises Chili's Grill & Bar and Maggiano's Little Italy restaurant brands. The company also operates virtual brands, It's Just Wings. Brinker International, Inc. was founded in 1975 and is headquartered in Dallas, Texas.Faircourt Gold IncomeTSE:FGXFaircourt Gold Income Corp. is a closed-ended equity mutual fund launched and managed by Faircourt Asset Management Inc. It invests in the public equity markets of Canada. The fund seeks to invest in stocks of companies operating in the precious metals sector, with an emphasis on companies involved in gold mining and exploration. It primarily invests in stocks of senior and intermediate gold producers that are part of the S&P/TSX Global Gold Index. The fund benchmarks the performance of its portfolio against S&P/TSX Global Gold Index. Faircourt Gold Income Corp. was formed on November 16, 2007 and is domiciled in Canada.PharmericaNYSE:PMCPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.